1. Home
  2. MG vs NVCT Comparison

MG vs NVCT Comparison

Compare MG & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mistras Group Inc

MG

Mistras Group Inc

N/A

Current Price

$20.21

Market Cap

642.4M

ML Signal

N/A

Logo Nuvectis Pharma Inc.

NVCT

Nuvectis Pharma Inc.

N/A

Current Price

$20.26

Market Cap

672.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MG
NVCT
Founded
1978
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
642.4M
672.1M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
MG
NVCT
Price
$20.21
$20.26
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
$21.18
★ $35.40
AVG Volume (30 Days)
★ 347.1K
185.6K
Earning Date
11-27-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.51
N/A
Revenue
★ $700,970,000.00
N/A
Revenue This Year
$3.15
N/A
Revenue Next Year
$5.40
N/A
P/E Ratio
$39.63
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.13
$5.77
52 Week High
$21.92
$29.28

Technical Indicators

Market Signals
Indicator
MG
NVCT
Relative Strength Index (RSI) 43.61 49.38
Support Level $20.06 $19.78
Resistance Level $21.77 $22.49
Average True Range (ATR) 0.11 1.41
MACD -0.04 0.19
Stochastic Oscillator 30.61 54.14

Price Performance

Historical Comparison
MG
NVCT

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International, and Products and Systems, of which key revenue is derived from the North America segment. The North America segment provides asset protection solutions, including NDT, inspection, and mechanical and engineering services, along with software, digital, and data services.

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Share on Social Networks: